SGX Regco Grants SAM Holdings' Extension for FY 2024 Results
SGX Regco Grants SAM Holdings' Extension for FY 2024 Results
They were also granted a two-month extension for the issuance of their AR2024 by 16 December, being at least 14 days before the date of its AGM. The company filed the application on 16 August with SGX Regco.
該公司於8月16日向新加坡交易所監管委員會（SGX Regco）提交了申請。
The Singapore Institute of Advanced Medicine Holdings Ltd. (SAM Holdings) application for extension to submit its fiscal year 2024 (FY 2024) earnings results has been granted by the Singapore Exchange Regulation (SGX Regco), according to a bourse filing.
根據證券交易所的申請，新加坡先進醫學控股有限公司（SAm Holdings）獲得了延長提交2024財年（FY2024）收益報告的批准。
This grants the company a two-month extension to release its FY 2024 results by 29 October and to convene its annual general meeting (AGM) by 31 December.
這使得該公司有兩個月的時間延長至10月29日發佈其2024財年業績，並於12月31日召開其年度股東大會（AGM）。
They were also granted a two-month extension for the issuance of their AR2024 by 16 December, being at least 14 days before the date of its AGM.
他們還獲准將AR2024的發佈期限延長兩個月，即12月16日，這是在大會日期前的至少14天。
Additionally, the company is also expected to file an application to the Accounting and Corporate Regulatory Authority (ACRA) for an extension to hold its AGM 2024.
此外，該公司還預計向會計和企業監管局（ACRA）申請延期舉行其2024年股東大會。
譯文內容由第三人軟體翻譯。
